Specifically, in genetically susceptible individuals, the formation rate of the citrullinated protein is high in lung tissues, and citrullination can trigger an immune response leading to the production of ACPA, resulting in an increased risk of RA in patients (Bongartz et al., 2010; Paulin et al., 2015). The gene discussed is PRTN3; the disease is rheumatoid arthritis.